(Q42345809)

27 October 2017

0 references

Early detection and aggressive treatment of prostate cancer: groping in the dark (English)

1 reference

27 October 2017

M J Barry

1

1 reference

27 October 2017

1 October 2000

1 reference

Journal of General Internal Medicine

27 October 2017

1 reference

27 October 2017

15

1 reference

27 October 2017

10

1 reference

27 October 2017

749-751

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1525-1497.2000.00816.x

27 October 2017

0 references

cites work

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Prostate cancer detection at low prostate specific antigen

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

The U.S. Postal Service and cancer screening--stamps of approval?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

A decision analysis for treatment of clinically localized prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Patient-re ported complications and follow-up treatment after radical prostatectomy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

29 May 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

29 May 2018

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.00816.X

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Population-based study of long-term survival in patients with clinically localised prostate cancer.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495598

Extended field prostate biopsies: too much of a good thing?

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.00816.X

Extended field prostate biopsy enhances cancer detection

21 January 2018

1 reference

12 December 2020

Lowering PSA cutoffs to enhance detection of curable prostate cancer

1 reference

12 December 2020

A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: the only rational approach for men 50 years old and older

1 reference

12 December 2020

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

1 reference

12 December 2020

10.1046/J.1525-1497.2000.00816.X

Identifiers

DOI

1 reference

PMC publication ID

1495598

Dimensions Publication ID

27 October 2017

0 references

1 reference

PMC publication ID

1495598

27 October 2017

PubMed publication ID

11089719

1 reference

PMC publication ID

1495598